Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many ...

Separate fact from fiction on obesity with expert insights! Debunk common myths and discover the truth about this complex ...

For more on Immunovant’s new data, go here; for more on Sarepta’s gene therapy, go here; to learn more about Zealand’s deal ...

Health data from people raised during sugar rationing offers insights on chronic disease. It’s hard to escape the fruit ...

By 2050, over half of the adults and one third of the youth may be obese. Experts have called for urgent action to prevent ...

The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many types of cancer. However ...

Obesity has long been classified as a global epidemic — and new data published in The Lancet journal spotlights how much ...

The demand for glucagon-like peptide 1 (GLP-1) receptor agonists for overweight/obesity has created a clinical conundrum for ...

Novo Nordisk on Monday revealed data from a second late-stage trial of its obesity drug candidate CagriSema, knocking shares ...

The Nevada Division of Health Care Financing and Policy, which houses the state’s Medicaid program, estimated the proposed ...